Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy

Acta Ophthalmologica

Volumn 90, Issue 8, 2012, Pages 738-743

  Pryds, Anders ^a,b   Larsen, Michael ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

central serous chorioretinopathy; choroidea; enhanced depth imaging optical coherence tomography; photodynamic treatment; retina; verteporfin

Indexed keywords

VERTEPORFIN;

ADULT; AGED; ARTICLE; CENTRAL SEROUS RETINOPATHY; CHOROID; CHOROID THICKNESS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA FOVEA; RETROSPECTIVE STUDY; TREATMENT DURATION; VISUAL ACUITY;

ADULT; AGED; CAPILLARY PERMEABILITY; CENTRAL SEROUS CHORIORETINOPATHY; CHOROID; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETINAL DETACHMENT; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84870493029     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2011.02157.x     Document Type: Article

References (22)

1. Fujiwara T, Imamura Y, Margolis R, Slakter JS, &, Spaide RF, (2009): Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol 148: 445-450.
2. Gass JD, (1967): Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 63 (Suppl.): 1-139.
3. Iida T, Kishi S, Hagimura N, &, Shimizu K, (1999): Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina 19: 508-512.
4. Imamura Y, Fujiwara T, Margolis R, &, Spaide RF, (2009): Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 29: 1469-1473.
5. Isola V, Pece A, &, Parodi MB, (2006): Choroidal ischemia after photodynamic therapy with verteporfin for choroidal neovascularization. Am J Ophthalmol 142: 680-683.
6. Margolis R, &, Spaide RF, (2009): A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 147: 811-815.
7. Marmor MF, (1988): New hypotheses on the pathogenesis and treatment of serous retinal detachment. Graefes Arch Clin Exp Ophthalmol 226: 548-552.
8. Maruko I, Iida T, Sugano Y, Ojima A, Ogasawara M, &, Spaide RF, (2010): Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 117: 1792-1799.
9. Moon JW, Yu HG, Kim TW, Kim HC, &, Chung H, (2009): Prognostic factors related to photodynamic therapy for central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 247: 1315-1323.
10. Negi A, &, Marmor MF, (1984): Experimental serous retinal detachment and focal pigment epithelial damage. Arch Ophthalmol 102: 445-449.
11. Piccolino FC, &, Borgia L, (1994): Central serous chorioretinopathy and indocyanine green angiography. Retina 14: 231-242.
12. Prunte C, &, Flammer J, (1996): Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 121: 26-34.
13. Pryds A, Sander B, &, Larsen M, (2010): Characterization of subretinal fluid leakage in central serous chorioretinopathy. Invest Ophthalmol Vis Sci 51: 5853-5857.
14. Schlotzer-Schrehardt U, Viestenz A, Naumann GO, Laqua H, Michels S, &, Schmidt-Erfurth U, (2002): Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefes Arch Clin Exp Ophthalmol 240: 748-757.
15. Schmidt-Erfurth U, Laqua H, Schlotzer-Schrehard U, Viestenz A, &, Naumann GO, (2002): Histopathological changes following photodynamic therapy in human eyes. Arch Ophthalmol 120: 835-844.
16. Spaide RF, (2009): Age-related choroidal atrophy. Am J Ophthalmol 147: 801-810.
17. Spaide RF, Koizumi H, &, Pozzoni MC, (2008): Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 146: 496-500.
18. Tarantola RM, Law JC, Recchia FM, Sternberg P Jr, &, Agarwal A, (2008): Photodynamic therapy as treatment of chronic idiopathic central serous chorioretinopathy. Lasers Surg Med 40: 671-675.
19. Wang MS, Sander B, &, Larsen M, (2002): Retinal atrophy in idiopathic central serous chorioretinopathy. Am J Ophthalmol 133: 787-793.
20. Wang M, Sander B, la CM, &, Larsen M, (2005): Clinical characteristics of subretinal deposits in central serous chorioretinopathy. Acta Ophthalmol Scand 83: 691-696.
21. Wang M, Munch IC, Hasler PW, Prunte C, &, Larsen M, (2008): Central serous chorioretinopathy. Acta Ophthalmol 86: 126-145.
22. Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa DL, Huang SJ, Klancnik JM Jr, &, Aizman A, (2003): Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 23: 288-298.